Study results have been selected for presentation at two prestigious scientific meetings and are advancing to publication
Covalon Technologies Ltd., an advanced medical technologies company, today announced that exciting results from a clinical study evaluating the use of its VALGuard Vascular Access Line Guard will be presented at two notable scientific meetings in the fall and are advancing through the publication process in a well-regarded academic journal.
The study, conducted independent of Covalon, was a prospective pre- and post- intervention study of VALGuard® across critical and acute care units focused on the reduction of Central Line-Associated Blood Stream Infections (CLABSIs).
“Blood streams infections are a serious, but largely preventable complication that tragically affect hundreds of thousands of patients each year, with a mortality rate estimated at 15% to 20%,” said Dr. Kate Evely, Vice President of Clinical Affairs for Covalon. “Major hospitals all over the United States are adding VALGuard® as an important part of their infection prevention program’s toolkit to protect intravenous lines from gross contamination, a known source of infection. The study results provide impactful real-world evidence on the use of VALGuard®. The forthcoming publication of this investigator-initiated study is a testament to the dedication of the research team and our shared goal of advancing patient care.”
As the authors advance the study through the final stages of the peer review process toward publication, they look forward to presenting their findings to their peers at two prestigious scientific conferences this fall – September’s Association for Vascular Access Annual Scientific Meeting, the premier platform for the latest innovations and technologies in vascular access, followed by October’s American Nurses Credentialing Center (ANCC) Magnet Pathway Conference, which attracts more than 11,000 nursing leaders and professionals from around the world.
Discover the latest trends and insights—explore the Business Insights Journal for up-to-date strategies and industry breakthroughs!
